Eiger Biopharmaceuticals, Inc.
- UEI
- KKQKH8T4GJM5
- CAGE
- 4VVJ0
- Primary NAICS
- 325412 Pharmaceutical Preparation Manufacturing
- SAM.gov registration
- Expired
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Other NAICS codes in SAM.gov
- SAM.gov registration date
- Website
- eigerbio.com
- Employees
- 51-250
- Estimated annual revenue
- $10M-$50M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract vehicles
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Xeris Pharmaceuticals, Inc. | Chicago, IL | 325412 Pharmaceutical Preparation Manufacturing |
| Biogen U.s. Corporation | Cambridge, MA | 325412 Pharmaceutical Preparation Manufacturing |
| Rhythm Pharmaceuticals, Inc. | Boston, MA | 325412 Pharmaceutical Preparation Manufacturing |
| Mirum Pharmaceuticals, Inc. | San Mateo, CA | 325412 Pharmaceutical Preparation Manufacturing |
| Ascendis Pharma, Inc. | — | 325412 Pharmaceutical Preparation Manufacturing |
About the company
Eiger Biopharmaceuticals, Inc. is a clinical stage biopharmaceutical company that develops and commercializes novel products for the treatment of orphan diseases. The company provides pharmaceuticals and drugs to the federal government through its GSA Schedule contract and associated Blanket Purchase Agreements.
Eiger Biopharmaceuticals holds a multiple-award Federal Supply Schedule contract under the GSA Pharmaceuticals and Drugs schedule, which has a potential value of $225,000. This contract, awarded by the Department of Veterans Affairs, allows Eiger to provide drugs, pharmaceuticals, and hematology-related products to VA medical facilities through January 2027. Under this contract, the VA National Acquisition Center awarded a $204,359.25 single-award Blanket Purchase Agreement to Eiger for its drug Zokinvy, used to treat Hutchinson-Gilford progeria syndrome. This BPA covers purchases of Zokinvy from January 2022 through January 2025. Eiger also holds a $205,000 single-award BPA from the VA National Acquisition Center for Zokinvy to treat progeroid laminopathies through May 2022. Additionally, Eiger was awarded an interim agreement under its VA FSS contract in July 2021, with a potential value of $25,000, to provide pharmaceuticals through January 2022.
Quick answers
Is Eiger Biopharmaceuticals, Inc. registered in SAM.gov?
Eiger Biopharmaceuticals, Inc.'s SAM.gov registration expired on January 14, 2026.
What is Eiger Biopharmaceuticals, Inc.'s CAGE code?
Eiger Biopharmaceuticals, Inc.'s CAGE code is 4VVJ0, and its Unique Entity ID (UEI) is KKQKH8T4GJM5.
Which contract vehicles does Eiger Biopharmaceuticals, Inc. hold?
Eiger Biopharmaceuticals, Inc. holds a place on 1 federal contract vehicle: FSS-61-IB.
On GovTribe
See Eiger Biopharmaceuticals, Inc.'s full federal record
- IDV awards
- Contract vehicles
- Funding analysis by agency, NAICS and set-aside
- Similar vendors